238 related articles for article (PubMed ID: 23429459)
1. Use and predictors of oral complementary and alternative medicine by patients with inflammatory bowel disease: a population-based, case-control study.
Koning M; Ailabouni R; Gearry RB; Frampton CM; Barclay ML
Inflamm Bowel Dis; 2013; 19(4):767-78. PubMed ID: 23429459
[TBL] [Abstract][Full Text] [Related]
2. Complementary and alternative medicine in patients with inflammatory bowel disease: the results of a population-based inception cohort study (IBSEN).
Opheim R; Hoivik ML; Solberg IC; Moum B;
J Crohns Colitis; 2012 Apr; 6(3):345-53. PubMed ID: 22405172
[TBL] [Abstract][Full Text] [Related]
3. Use of complementary and alternative medicine in patients with inflammatory bowel disease: results of a cross-sectional study in Norway.
Opheim R; Bernklev T; Fagermoen MS; Cvancarova M; Moum B
Scand J Gastroenterol; 2012 Dec; 47(12):1436-47. PubMed ID: 23003678
[TBL] [Abstract][Full Text] [Related]
4. Association of adherence to therapy and complementary and alternative medicine use with demographic factors and disease phenotype in patients with inflammatory bowel disease.
Lakatos PL; Czegledi Z; David G; Kispal Z; Kiss LS; Palatka K; Kristof T; Nagy F; Salamon A; Demeter P; Miheller P; Szamosi T; Banai J; Papp M; Bene L; Kovacs A; Racz I; Lakatos L
J Crohns Colitis; 2010 Sep; 4(3):283-90. PubMed ID: 21122517
[TBL] [Abstract][Full Text] [Related]
5. [Treatment adherence and use of complementary and alternative medicine in patients with inflammatory bowel disease].
Lakatos L; Czeglédi Z; Dávid G; Kispál Z; Kiss LS; Palatka K; Kristóf T; Molnár T; Salamon A; Demeter P; Miheller P; Szamosi T; Banai J; Papp M; Bene L; Kovács A; Rácz I; Lakatos PL
Orv Hetil; 2010 Feb; 151(7):250-8. PubMed ID: 20133244
[TBL] [Abstract][Full Text] [Related]
6. Regional variations in the use of complementary and alternative medicines (CAM) for inflammatory bowel disease patients in Italy: an IG-IBD study.
Bertomoro P; Renna S; Cottone M; Riegler G; Bossa F; Giglio L; Pastorelli L; Papi C; Castiglione F; Angelucci E; Pica R; Di Paolo MC; D'Incà R
J Crohns Colitis; 2010 Sep; 4(3):291-300. PubMed ID: 21122518
[TBL] [Abstract][Full Text] [Related]
7. Patterns of complementary and alternative medicine (CAM) use in patients with inflammatory bowel disease: perceived stress is a potential indicator for CAM use.
Langhorst J; Anthonisen IB; Steder-Neukamm U; Luedtke R; Spahn G; Michalsen A; Dobos GJ
Complement Ther Med; 2007 Mar; 15(1):30-7. PubMed ID: 17352969
[TBL] [Abstract][Full Text] [Related]
8. Amount of systemic steroid medication is a strong predictor for the use of complementary and alternative medicine in patients with inflammatory bowel disease: results from a German national survey.
Langhorst J; Anthonisen IB; Steder-Neukamm U; Lüdtke R; Spahn G; Michalsen A; Dobos GJ
Inflamm Bowel Dis; 2005 Mar; 11(3):287-95. PubMed ID: 15735435
[TBL] [Abstract][Full Text] [Related]
9. Use of complementary and alternative medicine (CAM) in patients with inflammatory bowel disease (IBD): results from a German nationwide survey of 2019 compared to a previous survey of 2002.
Bauer N; Kairey L; Schlee C; Uecker C; Öznur Ö; Langhorst J
Scand J Gastroenterol; 2022 Oct; 57(10):1209-1215. PubMed ID: 35722930
[TBL] [Abstract][Full Text] [Related]
10. Use of Complementary and Alternative Medicine for Inflammatory Bowel Disease Is Associated with Worse Adherence to Conventional Therapy: The COMPLIANT Study.
Nguyen GC; Croitoru K; Silverberg MS; Steinhart AH; Weizman AV
Inflamm Bowel Dis; 2016 Jun; 22(6):1412-7. PubMed ID: 27120570
[TBL] [Abstract][Full Text] [Related]
11. Experiences of complementary and alternative medicine in patients with inflammatory bowel disease - a qualitative study.
Lindberg A; Fossum B; Karlen P; Oxelmark L
BMC Complement Altern Med; 2014 Oct; 14():407. PubMed ID: 25338541
[TBL] [Abstract][Full Text] [Related]
12. The association between inflammatory bowel disease and periodontitis among Jordanians: a case-control study.
Habashneh RA; Khader YS; Alhumouz MK; Jadallah K; Ajlouni Y
J Periodontal Res; 2012 Jun; 47(3):293-8. PubMed ID: 22050539
[TBL] [Abstract][Full Text] [Related]
13. High incidence of Crohn's disease in Canterbury, New Zealand: results of an epidemiologic study.
Gearry RB; Richardson A; Frampton CM; Collett JA; Burt MJ; Chapman BA; Barclay ML
Inflamm Bowel Dis; 2006 Oct; 12(10):936-43. PubMed ID: 17012964
[TBL] [Abstract][Full Text] [Related]
14. Characterisation of complementary and alternative medicine use and its impact on medication adherence in inflammatory bowel disease.
Weizman AV; Ahn E; Thanabalan R; Leung W; Croitoru K; Silverberg MS; Steinhart AH; Nguyen GC
Aliment Pharmacol Ther; 2012 Feb; 35(3):342-9. PubMed ID: 22176478
[TBL] [Abstract][Full Text] [Related]
15. Complementary and Alternative Medicine Use in Children With Inflammatory Bowel Diseases: A Single-Center Survey.
Serpico MR; Boyle BM; Kemper KJ; Kim SC
J Pediatr Gastroenterol Nutr; 2016 Dec; 63(6):651-657. PubMed ID: 26960176
[TBL] [Abstract][Full Text] [Related]
16. Population-based cases control study of inflammatory bowel disease risk factors.
Gearry RB; Richardson AK; Frampton CM; Dodgshun AJ; Barclay ML
J Gastroenterol Hepatol; 2010 Feb; 25(2):325-33. PubMed ID: 20074146
[TBL] [Abstract][Full Text] [Related]
17. Rising Incidence of Inflammatory Bowel Disease in Canterbury, New Zealand.
Su HY; Gupta V; Day AS; Gearry RB
Inflamm Bowel Dis; 2016 Sep; 22(9):2238-44. PubMed ID: 27482976
[TBL] [Abstract][Full Text] [Related]
18. COMPLEMENTARY AND ALTERNATIVE MEDICINE USE IN BRAZILIAN PATIENTS WITH INFLAMMATORY BOWEL DISEASE.
Henriques DP; Oliveira RR; Vanni J; Lima HP; Otiti JV; Neves FRM; Hammerle MB; Sassaki LY; Zaltman C
Arq Gastroenterol; 2022; 59(3):375-382. PubMed ID: 36102435
[TBL] [Abstract][Full Text] [Related]
19. Asthma Is Associated With Subsequent Development of Inflammatory Bowel Disease: A Population-based Case-Control Study.
Kuenzig ME; Barnabe C; Seow CH; Eksteen B; Negron ME; Rezaie A; Panaccione R; Benchimol EI; Sadatsafavi M; Aviña-Zubieta JA; Kaplan GG
Clin Gastroenterol Hepatol; 2017 Sep; 15(9):1405-1412.e3. PubMed ID: 28344063
[TBL] [Abstract][Full Text] [Related]
20. Predictive factors of complementary and alternative medicine use for patients with inflammatory bowel disease in Korea.
Park DI; Cha JM; Kim HS; Park HJ; Shin JE; Hong SN; Hong SS; Kim WJ
Complement Ther Med; 2014 Feb; 22(1):87-93. PubMed ID: 24559822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
